| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/02/2007 | EP1576160B1 Borrelidin-derivatives and their use in medicine |
| 05/02/2007 | EP1575942B1 compounds having selective inhibiting efect at gsk3 |
| 05/02/2007 | EP1494692B1 Topical pharmaceutical compositions comprising proanthocyanidins, glycyrrhetinic acid and telmesteine for the treatment of dermatitis |
| 05/02/2007 | EP1458707B1 New Indol-2-one derivatives |
| 05/02/2007 | EP1358184B1 N-(3,3-Dimethylindolin-6-yl){2-[(4-pyridylmethyl)amino}(3-pyridyl)}carboxamide and pharmaceutical compositions thereof. |
| 05/02/2007 | EP1280826B1 Polypeptides for inhibiting april-mediated b- and t-cell proliferation. |
| 05/02/2007 | EP1227796A4 Cosmetic gel bead manufacturing method and apparatus |
| 05/02/2007 | EP1202734B1 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 05/02/2007 | EP1032405A4 Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 05/02/2007 | EP0912085B1 Precise efficacy assay methods for active agents including chemotherapeutic agents |
| 05/02/2007 | CN1956994A Epithelial cell growth promoter |
| 05/02/2007 | CN1956704A Skin lightening compositions comprising momordica charantia and pine extract |
| 05/02/2007 | CN1955180A 1,2,3,4,7,8-hexahydro-6H-[1,4]diazepino[6,7,1-IJ] quinoline derivatives as antipsychotic and antiobesity agents |
| 05/02/2007 | CN1954873A Traditional Chinese medicine composite and its preparation method |
| 05/02/2007 | CN1954847A Medicine for treating psoriasis |
| 05/02/2007 | CN1954812A Use of Edaravone |
| 05/02/2007 | CN1954804A Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 05/02/2007 | CN1313469C Novel derivative of flavone c-glycoside and composition containing the same |
| 05/02/2007 | CN1313464C Substituted alkylamine derivatives, preparing method thereof, composition comprising same and use thereof |
| 05/02/2007 | CN1313450C Tachykinin receptor antagonists |
| 05/02/2007 | CN1313449C New quinazoline hind derivative, medicinal composition containing same and their use |
| 05/02/2007 | CN1313448C Metalloproteinase inhibitors |
| 05/02/2007 | CN1313148C HSA-free formulations of interferon-Beta |
| 05/02/2007 | CN1313140C Oral Chinese medicine formulation for treating beri-beri |
| 05/02/2007 | CN1313124C Health medicinal wine for traumatic injury |
| 05/02/2007 | CN1313091C Vitamin C composition |
| 05/02/2007 | CN1313069C Composition for hair and/or scalp |
| 05/01/2007 | USRE39608 Substituted benzimidazoles and their use as PARP inhibitors |
| 05/01/2007 | US7211694 Substituted 4-aminocyclohexanols |
| 05/01/2007 | US7211680 (5Z,7E,22E)-(1S,3R,24R)-25-phenyl-26,27-cyclo-9,10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol; treating hyperprolifierative diseases of the skin, tumor diseases and precancerous stages, auto-immune diseases, rejection reactions in the case of autologous, allogenic or xenogenic transplants, AIDS |
| 05/01/2007 | US7211656 Using the enzymes to make polyunsaturated fatty acids; added to pharmaceutical compositions, nutritional compositions, animal feeds, cosmetics |
| 05/01/2007 | US7211604 Hormone inhibitors comprising carbocyclic ketones such as 3-(5-methoxyheptyl)-2-cyclohexenone used for prophylaxis of acne, alopecia, keloids or osteoarthritis |
| 05/01/2007 | US7211598 Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 05/01/2007 | US7211590 Such as 2-(nitrooxy)ethyl-2-(((3-methyl-4-(2,2,2-trifluoro-ethoxy)-2 -pyridyl)methyl)sulfinyl)benzimidazolecarboxylate; kits; for treating gastrointestinal disorders/ulcers |
| 05/01/2007 | US7211589 Atisane compounds and use thereof |
| 05/01/2007 | US7211587 Administering compounds such as N-{3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)-oxy]phenyl}-N'-(3-isoxazolyl)urea for therapy of malignant tumors |
| 05/01/2007 | US7211586 Substituted tetrahydroisoquinolines |
| 05/01/2007 | US7211578 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with TNF activity |
| 05/01/2007 | US7211269 peptide of sequence (Gly-Pro-Gln)n-NH2, wherein n ranges between 1 and 3; to enhance skin appearance |
| 05/01/2007 | US7211258 Protein A compositions and methods of use |
| 05/01/2007 | CA2392917C Pin1 as a marker for abnormal cell growth |
| 05/01/2007 | CA2269594C Use of complexes for the preparation of compositions for the treatment of sensitive skin, preparation process and hypoallergenic compositions |
| 05/01/2007 | CA2227205C Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles |
| 05/01/2007 | CA2129773C Aromatic carboxylic acid derivatives |
| 04/30/2007 | CA2524990A1 Oral skin supplement |
| 04/26/2007 | WO2007046775A1 Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom |
| 04/26/2007 | WO2007046544A1 Preparation for external application comprising salt of mast cell degranulation inhibitor having carboxyl group with organic amine |
| 04/26/2007 | WO2007046392A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 04/26/2007 | WO2007046353A1 Fibroblast activator, method for activation of fibroblast, collagen synthesis promoter, method for promotion of collagen synthesis, skin aging-preventing agent, and method for prevention of aging of the skin |
| 04/26/2007 | WO2007046315A1 External preparation for skin |
| 04/26/2007 | WO2007045982A2 Use of collagen in combination with oxygen- and ozonereleasing perfluorocarbons for the preparation of a medicament for the treatment of skin lesions |
| 04/26/2007 | WO2007045693A1 Novel unsaturated fatty hydroxy acid derivatives and the dermocosmetologic use thereof |
| 04/26/2007 | WO2007045116A1 Treatment and prevention of benign pigmented moles (naevi) using artemisinine and the derivatives thereof |
| 04/26/2007 | WO2006136540A3 Human skin regenerating ointment comprising annelid extracts |
| 04/26/2007 | WO2006067165A3 Indolidone derivatives for the treatment or prevention of fibrotic diseases |
| 04/26/2007 | US20070093512 4-Phenylaminopyrido[4,3-d]pyrimidines 6-heteroaryl-substituted, in which the heteroaryl is substituted with a sulfonylethylamino-, thio- or oxy- group; protein tyrosine kinase inhibitors, used especially to treat various malignancies |
| 04/26/2007 | US20070093487 Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 04/26/2007 | US20070093419 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 04/26/2007 | US20070093418 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 04/26/2007 | US20070093416 Human beta-defensin secretion promoter |
| 04/26/2007 | US20070092540 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof |
| 04/26/2007 | US20070092466 in combination with carrier, and optionally activity enhancer; arresting or reversing hair loss, or both, and promoting hair growth; also a mascara; thickening and darkening hair |
| 04/26/2007 | DE10327489B4 Verwendung von Bestandteilen von Dipteren-Puppen zur Behandlung von Wunden Use of components of Diptera dolls for the treatment of wounds |
| 04/26/2007 | DE102005051862A1 Emulsion for treating e.g. skin aging comprises a lipid phase of polar and/or moderately polar, having specified interfacial tension toward water; and at least one 1,2-alkanediol having specified 1-octanol/water distribution coefficient |
| 04/26/2007 | CA2626704A1 Treatment and prevention of benign pigmented moles (naevi) using artemisinine and the derivatives thereof |
| 04/26/2007 | CA2626635A1 Novel unsaturated fatty hydroxy acid derivatives and the dermocosmetologic use thereof |
| 04/26/2007 | CA2626361A1 Pharmaceutical compositions and diagnostic methods for inflammatory skin diseases, disorders or conditions |
| 04/26/2007 | CA2626181A1 Modulation of trpv expression levels |
| 04/26/2007 | CA2624492A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 04/25/2007 | EP1777234A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 04/25/2007 | EP1777220A1 Vitamin D derivatives active on the vitamin D nuclear receptor, preparation and uses thereof |
| 04/25/2007 | EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives |
| 04/25/2007 | EP1776960A1 Use of collagen in combination with oxygen- and ozone-releasing perfluorocarbons for the preparation of a medicament for the treatment of skin lesions. |
| 04/25/2007 | EP1776959A2 Use of HGF for the manufacture of a medicament for treating fibrotic disorders |
| 04/25/2007 | EP1776366A1 Immunomodulating oxopyrrazolocinnolines as cd80 inhibitors |
| 04/25/2007 | EP1776138A1 tRNA SYNTHETASE FRAGMENTS |
| 04/25/2007 | EP1776137A1 Pharmaceutical composition containing botulinum neurotoxin a2 |
| 04/25/2007 | EP1776119A1 Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulators |
| 04/25/2007 | EP1646359B1 Preparation for topical use with the function of combating hair loss |
| 04/25/2007 | EP1526867B1 Erythropoietin in subpolycythemic doses |
| 04/25/2007 | EP1430133B1 A soluble toll-like receptor |
| 04/25/2007 | EP1392335B1 Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite |
| 04/25/2007 | EP1305294B1 Imidazolyl derivatives |
| 04/25/2007 | EP1254174B1 Human cyr61 |
| 04/25/2007 | EP1049468B1 Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers |
| 04/25/2007 | EP0949865A4 The use of cd4-binding small molecules to inhibit immune responses |
| 04/25/2007 | EP0866656B1 Use of n-substituted pyridones as tumor necrosis factor alpha inhibitors |
| 04/25/2007 | CN1953968A Thiazole compound and use thereof |
| 04/25/2007 | CN1953783A Treatment of diseases |
| 04/25/2007 | CN1953742A Use of idebenone for the preparation of a topically-applied depigmentation composition and corresponding composition |
| 04/25/2007 | CN1953732A Topical cypress essential oil composition for stretch marks |
| 04/25/2007 | CN1951939A Novel pyrrole derivatives as pharmaceutical agents |
| 04/25/2007 | CN1951899A Aspirin-triggered lipid mediators |
| 04/25/2007 | CN1951488A Medicament for treating psoriasis and preparation method thereof |
| 04/25/2007 | CN1951487A Drink capable of treating wart |
| 04/25/2007 | CN1951485A An antivirus medicament |
| 04/25/2007 | CN1951484A Oil for treating wounds |
| 04/25/2007 | CN1951477A Compound Chinese medicinal preparation for treating acne and preparation method thereof |
| 04/25/2007 | CN1951476A Medicinal prescription for treating dark face and hair loss |
| 04/25/2007 | CN1951463A Medicinal ointment for treating burn and knife wound without leaving scar |